FFBTD
CAPR icon

First Financial Bank - Trust Division’s Capricor Therapeutics CAPR Stock Holding History

First Financial Bank - Trust Division’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-28,089
Closed -$203K – 208
2025
Q3 		$203K Buy
+28,089
New +$207K 0.02% 209

Other funds holding CAPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Financial Bank - Trust Division's CAPR Position: Q4 2025 in Review

First Financial Bank - Trust Division sold out of Capricor Therapeutics (CAPR) in Q4 2025, closing a stake of 28,089 shares — an estimated $203K sold.

First Financial Bank - Trust Division first reported a position in CAPR in Q3 2025 and held it in 1 quarter. The position peaked at $203K in Q3 2025. 132 funds tracked by Wall St. Rank hold CAPR as of Q4 2025.

  • First Financial Bank - Trust Division reported no remaining Capricor Therapeutics position as of Q4 2025 after selling out during the quarter.
  • First Financial Bank - Trust Division sold 28,089 Capricor Therapeutics shares in Q4 2025, an estimated $203K.
  • First Financial Bank - Trust Division first reported a position in Capricor Therapeutics in Q3 2025 and held it in 1 quarter.
  • First Financial Bank - Trust Division's Capricor Therapeutics position peaked at $203K in Q3 2025.
  • 132 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q4 2025.

Based on First Financial Bank - Trust Division's 13F filing for Q4 2025, filed 2 Jan 2026.